# Strata Critical Medical Inc. (SRTA) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Health Care Providers & Services. Price $5.32, market value $471 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Strata Critical Medical Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 2.0×**. Each dollar of revenue is priced at 2.0×.
- **Price / book: 1.7×**. The shares trade at 1.7× book value; book value is a meaningful part of the valuation.
- **Free-cash-flow yield: -10.3%** (5-yr avg -11.1%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Operating margin: -8.7%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: 21.0%**. 21.0% of each dollar of sales reaches the bottom line.
- **Return on equity: 14.8%**. 14.8% on shareholders' equity is solid.
- **Return on invested capital: -6.4%**. Return on all capital, debt included, is -6.4%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: 12.4%**. Each dollar of assets produces 12.4% of profit.

## Growth
- **Revenue growth (1 yr): 34.3%** (3-yr 10.5%/yr). Revenue grew 34.3% over the last year.
- **EPS growth (1 yr): 242.9%**. Earnings per share rose 242.9%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Debt to equity: 0.00**. Debt is 0.00 times equity: a conservative balance sheet.
- **Net debt / EBITDA: 8.1×**. It would take 8.1 years of operating earnings to repay net borrowings, above the 3× level most lenders treat as comfortable.
- **Current ratio: 6.38** (quick 6.38). Current assets cover the next year's liabilities 6.38 times.
- **Altman Z-score: 8.06**. A Z-score of 8.06 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 5/9**. 5 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Strata Critical Medical Inc. does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): 27.3%** (YTD 10.6%, 3-mo -8.1%). The shares are up 27.3% over twelve months including dividends.
- **From 52-week high: -18.2%** (38.2% above the low). Trading 18% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 40**. An RSI of 40 is neutral.
- **Beta (1 yr): 2.18** (volatility 60%). Beta of 2.18 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=SRTA · Page: https://foliofundamentals.com/stocks/srta

Not investment advice.